Sanofi

Sanofi’s Fluzone High-Dose Demonstrates Superior Protection Against Hospitalization in Older Adults

Sanofi’s Fluzone High-Dose Demonstrates Superior Protection Against Hospitalization in Older Adults

22 Oct 2025

2 min read

Revvity Expands Type 1 Diabetes Offering with Support from Sanofi

Revvity Expands Type 1 Diabetes Offering with Support from Sanofi

04 Oct 2025

2 min read

CHMP Recommends EU Approval of Dupixent for Chronic Spontaneous Urticaria

CHMP Recommends EU Approval of Dupixent for Chronic Spontaneous Urticaria

23 Sep 2025

1 min read

Read More

Voice Of HealthCare

vohnetwork.com